1. ホーム
  2. 一覧
論文 特許

論文 - 一覧

  • 11 Hits
  • 検索条件 : 絞込み (MeSH = Aniline Compounds / pharmacology*)
生物種 リソース名 タイトル
ヒト・動物細胞 Ca9-22(RCB1976) , A549 Effects and Related Mechanisms of the Senolytic Agent ABT-263 on the Survival of Irradiated A549 and Ca9-22 Cancer Cells.
ヒト・動物細胞 PC-9(RCB4455) Identification of optimal dosing schedules of dacomitinib and osimertinib for a phase I/II trial in advanced EGFR-mutant non-small cell lung cancer.
ヒト・動物細胞 PC-9(RCB4455) EphB4 as a Novel Target for the EGFR-Independent Suppressive Effects of Osimertinib on Cell Cycle Progression in Non-Small Cell Lung Cancer.
ヒト・動物細胞 PC-9(RCB4455) Activation of AXL as a Preclinical Acquired Resistance Mechanism Against Osimertinib Treatment in EGFR-Mutant Non-Small Cell Lung Cancer Cells.
ヒト・動物細胞 PC-9(RCB4455) ONO-7475, a Novel AXL Inhibitor, Suppresses the Adaptive Resistance to Initial EGFR-TKI Treatment in EGFR-Mutated Non-Small Cell Lung Cancer.
ヒト・動物細胞 PC-9(RCB4455) , A549(RCB0098) Brexpiprazole Reduces Survivin and Reverses EGFR Tyrosine Kinase Inhibitor Resistance in Lung and Pancreatic Cancer.
遺伝子材料 pCMV-VSV-G-RSV-Rev (RDB04393) , pCAG-HIVgp (RDB04394) , pENTR4-H1tetOx1 (RDB07916) , CS-RfA-ETBsd (RDB07917) CBP-93872 inhibits NBS1-mediated ATR activation, abrogating maintenance of the DNA double-strand break-specific G2 checkpoint.
ヒト・動物細胞 Ba/F3(RCB0805) Effects of secondary EGFR mutations on resistance against upfront osimertinib in cells with EGFR-activating mutations in vitro.
ヒト・動物細胞 PANC-1(RCB2095) The G2 checkpoint inhibitor CBP-93872 increases the sensitivity of colorectal and pancreatic cancer cells to chemotherapy.
ヒト・動物細胞 CACO-2(RCB0988) , CW-2(RCB0778) HUHS1015 Suppresses Colonic Cancer Growth by Inducing Necrosis and Apoptosis in Association with Mitochondrial Damage.
ヒト・動物細胞 293T(RCB2202) , HeLa MIP-2A is a novel target of an anilinoquinazoline derivative for inhibition of tumour cell proliferation.